Thyroid Cancer

Lower Thyroid Stimulating Hormone Levels Elevate Risk of Thyroid Cancer (09-20-2017)

There is an increased risk of thyroid cancer associated with lower-than-normal thyroid hormone levels, a finding that could have a major impact on patients fighting the disease. The Yale-led study, published in American Association for Cancer Research... Continue Reading

Pass it On: It’s National Thyroid Awareness Month (09-8-2017)

The thyroid gland is a butterfly-shaped organ that is below the Adam’s apple in the front part of the neck. It produces, stores, and releases hormones that regulate vital body functions. Thyroid cancer happens when cells in the thyroid grow out of control.... Continue Reading

Targeted Therapies Show Initial Effectiveness in Subset of Papillary Thyroid Cancer (06-6-2017)

Two immunotherapy drugs currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of melanoma also show promise for treating a rare but aggressive form of papillary thyroid cancer. Up to 44 percent of papillary thyroid cancer... Continue Reading

Thyroid Cancer Survivors May Have Increased Risk of Osteoporosis and Heart Conditions (03-3-2017)

The results of a recent new study find that younger survivors of thyroid cancer are at increased risk for osteoporosis, high blood pressure and heart disease.  Thyroid cancer is the fifth most common cancer in women. The thyroid gland is a butterfly-shaped... Continue Reading

Complications Decrease with Surgeon Experience in Thyroidectomy (04-6-2016)

Among patients undergoing the surgical removal of their thyroid, complications associated with the procedure are drastically reduced if surgeons perform a larger number of the surgeries per year. These results were recently published in the Annals of... Continue Reading

Lenvima® (05-28-2015)

Class: Biological Therapy Generic Name: Lenvatinib Trade Name: Lenvima® For which conditions is this drug approved? Lenvima is approved to treat people with a type of thyroid cancer called differentiated thyroid cancer (DTC) when the disease can no... Continue Reading

Lenvatinib (05-28-2015)

Class: Biological Therapy Generic Name: Lenvatinib Trade Name: Lenvima® For which conditions is this drug approved? Lenvima is approved to treat people with a type of thyroid cancer called differentiated thyroid cancer (DTC) when the disease can no... Continue Reading

More Risk than Benefit with TSH Suppression in Thyroid Cancer without High Risk of Recurrence (05-21-2015)

For patients undergoing treatment for thyroid cancer who aren’t at high risk of recurrence, therapy to suppress thyrotropin (TSH) may be ineffective as well as risky. These findings were published in the journal Thyroid. Differentiated thyroid cancer... Continue Reading

Target Therapy Sutent® Promising in Advanced Thyroid Cancer (05-19-2015)

The targeted therapy Sutent® (sunitinib) appears effective in the treatment of patients with advanced differentiated thyroid cancers. The Endocrine Society announced these Phase II trial findings in a press release. Study results were also presented... Continue Reading

Important Clues in the Development of Aggressive Thyroid Cancer (04-16-2015)

New insight into how anaplastic thyroid cancer (ATC) grows and spreads may provide important direction in the development of treatment. These findings were published in the Journal of Clinical Endocrinology and Metabolism. The thyroid is a gland in the... Continue Reading

Next Page »